Chronic Hepatitis
Department of Gastroenterology Details Research in Chronic Hepatitis
Published in Hepatitis Weekly, January 9th, 2012
2012 JAN 9 -- "The aim of this study was to evaluate the efficacy of pegylated interferon (PEG-IFN) alfa-2b for short (one year) and long (two years) terms of treatment for chronic hepatitis D. Eighteen patients with chronic hepatitis D were administered PEG-IFN alfa-2b 1.5 mu g/kg twice weekly for 1 month, after which they were randomly assigned (2:1) to receive PEG-TEN alfa-2b 1.5 mu g/kg/wk for an additional 23 months (n=11; group 1) or 11 months (n=7; group 2). All patients were followed-up for 6 months after completing therapy," scientists writing in the journal Hepato-Gastroenterology report.
"In group 1, there was no significant difference...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2012-01-09)
More Articles from Hepatitis Weekly
- Immunoglobulins
Study Data from University of Punjab Provide New Insights into Immunoglobulins - Genetic Research
Scientists at Christian Medical College Discuss Research in Genetic Research - Liver Diseases
New Findings in Liver Diseases Described from Tripler Army Medical Center - Chronic Hepatitis C Virus
New Chronic Hepatitis C Virus Research Has Been Reported by Investigators at Tohoku University - Chronic Hepatitis
New Data from Mayo Clinic Illuminate Research in Chronic Hepatitis - Thrombocytopenia
Findings in Thrombocytopenia Reported from Department of Surgery - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
